Certain older radiotherapies and chemotherapies have been the mainstays of cancer treatment for literally decades. But now, a new generation of radiotherapies are redefining cancer care. These therapies have the promise of destroying cancer cells while leaving healthy cells relatively unscathed.
Instead of delivering the radiation from outside the body, by combining a nuclear isotope with an antibody, the microscopic drugs — known as radioligands — deliver a toxic payload directly to cancer cells, minimizing damage to other tissue.
